Latest Insider Transactions at Oyster Point Pharma, Inc. (OYST)
This section provides a real-time view of insider transactions for Oyster Point Pharma, Inc. (OYST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oyster Point Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oyster Point Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2023
|
Inv Opps Gp Iv, L.L.C. Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,768,586
-100.0%
|
-
|
|
Jan 03
2023
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,420,730
-100.0%
|
-
|
|
Jan 03
2023
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,236,888
-100.0%
|
-
|
|
Jan 03
2023
|
Aimee S Weisner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
36,764
-95.14%
|
-
|
|
Jan 03
2023
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,925,287
-100.0%
|
-
|
|
Jan 03
2023
|
Ali Behbahani Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,639
-86.9%
|
-
|
|
Jan 03
2023
|
Michael G Atieh Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,671
-100.0%
|
-
|
|
Jan 03
2023
|
Michael G Atieh Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
18,063
-67.57%
|
-
|
|
Jan 03
2023
|
George Christopher Eliades Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,624
-70.54%
|
-
|
|
Jan 03
2023
|
Daniel Lochner Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,236
-100.0%
|
-
|
|
Jan 03
2023
|
Daniel Lochner Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
56,289
-73.56%
|
-
|
|
Jan 03
2023
|
Mark Anthony Murray Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
122,086
-98.54%
|
-
|
|
Jan 03
2023
|
Jeffrey Nau President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,000
-100.0%
|
-
|
|
Jan 03
2023
|
Jeffrey Nau President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,975
-100.0%
|
-
|
|
Jan 03
2023
|
Jeffrey Nau President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
100,738
-67.74%
|
-
|
|
Jan 03
2023
|
Clare Ozawa Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
3,657,618
-100.0%
|
-
|
|
Jan 03
2023
|
Clare Ozawa Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,637
-87.79%
|
-
|
|
Jan 03
2023
|
Donald J Santel Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,198
-100.0%
|
-
|
|
Jan 03
2023
|
Donald J Santel Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,489
-40.1%
|
-
|
|
Jan 03
2023
|
Benjamin Tsai Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,573
-100.0%
|
-
|
|
Jan 03
2023
|
Benjamin Tsai Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,066
-73.8%
|
-
|
|
Dec 01
2022
|
Daniel Lochner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,258
-4.19%
|
$35,838
$11.2 P/Share
|
|
Dec 01
2022
|
Jeffrey Nau President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,217
-3.94%
|
$68,387
$11.2 P/Share
|
|
Jun 06
2022
|
Donald J Santel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+20.7%
|
-
|
|
Jun 06
2022
|
Michael G Atieh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+11.79%
|
-
|
|
Jun 06
2022
|
Mark Anthony Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+2.84%
|
-
|
|
Jun 06
2022
|
Benjamin Tsai Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+20.76%
|
-
|
|
Jun 06
2022
|
Aimee S Weisner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+8.86%
|
-
|
|
Jun 06
2022
|
George Christopher Eliades Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+11.1%
|
-
|
|
Jun 06
2022
|
Clare Ozawa Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+19.62%
|
-
|
|
Jun 06
2022
|
Ali Behbahani Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+20.76%
|
-
|
|
Jan 29
2022
|
Daniel Lochner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
938
-1.21%
|
$10,318
$11.7 P/Share
|
|
Jan 29
2022
|
Jeffrey Nau President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,607
-1.72%
|
$28,677
$11.7 P/Share
|
|
Jan 09
2022
|
Daniel Lochner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+20.06%
|
-
|
|
Jan 09
2022
|
Jeffrey Nau President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
46,700
+22.86%
|
-
|
|
Jan 09
2022
|
John Snisarenko Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,100
+28.52%
|
-
|
|
Jan 05
2022
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-55.47%
|
-
|
|
Jan 05
2022
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
120
+1.07%
|
-
|
|
Jan 05
2022
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Jan 05
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-55.47%
|
-
|
|
Jan 05
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Jan 05
2022
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
6,839
+16.17%
|
-
|
|
Dec 21
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-49.95%
|
-
|
|
Dec 21
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Dec 21
2021
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-49.95%
|
-
|
|
Dec 21
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
120
+1.08%
|
-
|
|
Dec 21
2021
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Dec 21
2021
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
6,838
+19.26%
|
-
|
|
Nov 01
2021
|
Daniel Lochner Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,590
+12.86%
|
$94,490
$11.51 P/Share
|
|
Oct 21
2021
|
Jeffrey Nau President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+31.08%
|
$50,000
$1.02 P/Share
|